Fulcrum Therapeutics

Developing small molecules for control mechanisms and genes regulation for the treatment of rare diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2015 groups104 employees language fulcrumtx.com

Registered entities

Innovation

19 patent families (5 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 2,869 times.

YearFilings
20182
20192
20204
20214
20228
20238
20248
20256
20265

Social engagement

Social engagement: 14.4K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

17 investors on record; lead investors include Third Rock Ventures, Google Ventures, Foresite Capital.

Investor typeCountShare
Venture capital1165%
Bank & private debt16%
Other / undisclosed529%

Hiring activity

Hires occasionally

2 roles tracked across 2 of the last 12 months

1 May 2026 · Director-level roles across Analytical Chemistry, Biostatistics, Pharmapharmaceutical Development

9 Mar 2026 · Clinical Trial Manager · Cambridge

30 Aug 2025 · Director, Clinical Quality Assurance · Cambridge

30 Aug 2025 · Associate Director/Director, Clinical Operations · Cambridge

30 Aug 2025 · Director, Head of Medical Writing · Cambridge

Based on job postings tracked across public sources.

Recent activity

27 Apr 2026
Leadership hire
Board of Directors
22 Apr 2026
Recognition
Coming soon